The Benevolent PlatformTM empowers scientists with industry leading drug discovery AI
End-to- end Drug discovery offerings
Clinical sub-typing
Mechanism recommandation
Target prediction & assessment
Experimental hypothesis validation
In-silico led HitID
In-silico led LeadOp
Biomarker assessment
Indication expansion / Drug repurposing
